Addus HomeCare Corporation (ADUS) 10-Year Financial Performance & Capital Metrics

ADUS •

HealthcareHealthcare FacilitiesHome-based care services

AboutAddus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2021, the company served consumers through 206 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.Show more

Revenue $1.42B +23.2%
EBITDA $155M +33.4%
Net Income $96M +30.3%
EPS (Diluted) 5.21 +23.2%
Gross Margin 32.47%
EBITDA Margin 10.9% +8.3%
Operating Margin 9.74% +9.6%
Net Margin 6.74% +5.8%
ROE 9.33% +6.3%
ROIC 8.82% +12.3%
Debt/Equity 0.19 -31.7%
Interest Coverage 14.46 +8.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 23.7%
✓Strong Piotroski F-Score: 7/9
✓Strong 5Y sales CAGR of 13.2%

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y15.5%

5Y13.22%

3Y14.36%

TTM23.21%

Profit (Net Income) CAGR

10Y23.5%

5Y23.69%

3Y27.73%

TTM30.32%

EPS CAGR

10Y17.48%

5Y20.16%

3Y22.42%

TTM22.88%

ROCE

10Y Avg9.42%

5Y Avg9.61%

3Y Avg10.43%

Latest10.89%

Peer Comparison

Home-based care services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
OPCHOption Care Health, Inc.	5.09B	32.46	25.36	13.03%	3.67%	15.65%	5.08%
CHEChemed Corporation	5.78B	410.01	22.26	4.06%	10.48%	27.08%	5.63%	0.15
ADUSAddus HomeCare Corporation	1.92B	103.53	19.87	23.21%	6.74%	8.84%		0.19
DCGODocGo Inc.	73.17M	0.72	3.99	-1.24%	-14.02%	-19.79%	88.15%	0.18
EHABEnhabit, Inc.	685.94M	13.61	-4.38	-1.1%	-1.14%	-1.99%	6.91%	1.03
AVAHAveanna Healthcare Holdings Inc.	1.53B	7.36	-129.81	6.82%	0.85%		1.72%

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	400.69M	425.71M	518.12M	648.79M	764.77M	864.5M	951.12M	1.06B	1.15B	1.42B
Revenue Growth %	18.96%	6.25%	21.71%	25.22%	17.88%	13.04%	10.02%	11.31%	9.06%	23.21%
Cost of Goods Sold+	294.59M	310.12M	379.84M	469.55M	538.54M	595.24M	651.38M	718.77M	779.58M	960.66M
COGS % of Revenue	73.52%	72.85%	73.31%	72.37%	70.42%	68.85%	68.49%	67.9%	67.52%	67.53%
Gross Profit+	106.09M	115.6M	138.28M	179.24M	226.24M	269.85M	299.74M	339.88M	375.02M	461.87M
Gross Margin %	26.48%	27.15%	26.69%	27.63%	29.58%	31.21%	31.51%	32.1%	32.48%	32.47%
Gross Profit Growth %	16.18%	8.96%	19.62%	29.62%	26.22%	19.28%	11.08%	13.39%	10.34%	23.16%
Operating Expenses+	90.86M	91.82M	113.94M	144.49M	181.73M	203.32M	231M	248.92M	272.33M	323.26M
OpEx % of Revenue	22.68%	21.57%	21.99%	22.27%	23.76%	23.52%	24.29%	23.51%	23.59%	22.72%
Selling, General & Admin	84.21M	76.9M	105.03M	133.57M	169.68M	189.42M	216.94M	231.68M	258.8M	306.85M
SG&A % of Revenue	21.02%	18.06%	20.27%	20.59%	22.19%	21.91%	22.81%	21.88%	22.41%	21.57%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	6.65M	14.92M	8.91M	10.92M	12.05M	13.9M	14.06M	17.24M	13.53M	16.41M
Operating Income+	15.48M	25.25M	22.83M	34.75M	44.51M	65.94M	68.74M	90.96M	102.69M	138.62M
Operating Margin %	3.86%	5.93%	4.41%	5.36%	5.82%	7.63%	7.23%	8.59%	8.89%	9.74%
Operating Income Growth %	-3.42%	63.18%	-9.61%	52.24%	28.07%	48.15%	4.25%	32.32%	12.9%	34.98%
EBITDA+	22.12M	31.92M	31.47M	45.33M	56.56M	80.43M	82.8M	105.08M	116.22M	155.03M
EBITDA Margin %	5.52%	7.5%	6.07%	6.99%	7.4%	9.3%	8.71%	9.93%	10.07%	10.9%
EBITDA Growth %	6.66%	44.27%	-1.4%	44.03%	24.78%	42.21%	2.94%	26.92%	10.6%	33.39%
D&A (Non-Cash Add-back)	6.65M	6.66M	8.64M	10.57M	12.05M	14.49M	14.06M	14.13M	13.53M	16.41M
EBIT	18.25M	26.65M	25.42M	36.27M	45.13M	66.2M	69.08M	92.43M	107.08M	137.03M
Net Interest Income+	480K	-4.41M	-2.42M	-1.58M	-2.56M	-5.54M	-8.57M	-9.63M	-3.34M	-8M
Interest Income	2.81M	66K	2.59M	1.52M	624K	268K	341K	1.48M	4.39M	1.59M
Interest Expense	2.33M	4.47M	5.02M	3.1M	3.19M	5.81M	8.91M	11.11M	7.73M	9.58M
Other Income/Expense	686K	-5.17M	-2.42M	-1.58M	-2.56M	-5.54M	-8.57M	-9.63M	-3.34M	-11.17M
Pretax Income+	16.16M	21.06M	20.4M	33.17M	41.94M	60.4M	60.17M	81.33M	99.35M	127.44M
Pretax Margin %	4.03%	4.95%	3.94%	5.11%	5.48%	6.99%	6.33%	7.68%	8.61%	8.96%
Income Tax+	4.1M	9.26M	4.1M	7.36M	8.81M	15.27M	14.15M	18.81M	25.75M	31.54M
Effective Tax Rate %	74.4%	64.6%	85.79%	76.08%	79%	74.71%	76.49%	76.87%	74.08%	75.26%
Net Income+	12.02M	13.61M	17.5M	25.24M	33.13M	45.13M	46.02M	62.52M	73.6M	95.91M
Net Margin %	3%	3.2%	3.38%	3.89%	4.33%	5.22%	4.84%	5.91%	6.37%	6.74%
Net Income Growth %	3.45%	13.17%	28.62%	44.19%	31.29%	36.2%	1.99%	35.83%	17.73%	30.32%
Net Income (Continuing)	12.06M	13.53M	16.31M	25.81M	33.13M	45.13M	46.02M	62.52M	73.6M	95.91M
Discontinued Operations	97K	147K	126K	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	1.04	1.17	1.33	1.77	2.08	2.81	2.84	3.83	4.23	5.21
EPS Growth %	0%	12.5%	13.68%	33.08%	17.51%	35.1%	1.07%	34.86%	10.44%	23.17%
EPS (Basic)	1.04	1.17	1.33	1.83	2.12	2.87	2.90	3.91	4.33	5.19
Diluted Shares Outstanding	11.53M	11.63M	13.13M	14.25M	15.96M	16.06M	16.18M	16.31M	17.38M	18.45M
Basic Shares Outstanding	11.29M	11.47M	13.13M	13.82M	15.83M	15.74M	16.13M	16.23M	17.01M	18.45M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	131.01M	155.67M	176.01M	269.39M	287.7M	324.34M	222.81M	200M	260.38M	269.49M
Cash & Short-Term Investments	8.01M	53.75M	70.41M	111.71M	145.08M	168.9M	79.96M	64.79M	98.91M	81.62M
Cash Only	8.01M	53.75M	70.41M	111.71M	145.08M	168.9M	79.96M	64.79M	98.91M	81.62M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	117.75M	93.53M	100.57M	153.24M	134.51M	146.07M	126.17M	116.08M	135.26M	151.69M
Days Sales Outstanding	107.26	80.19	70.85	86.21	64.2	61.67	48.42	40.02	42.76	38.92
Inventory	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	1.82M	4.7M	5.04M	2.4M	2.18M	2.49M	5.39M	2.23M	7.83M	36.18M
Total Non-Current Assets+	100.02M	116.03M	169.88M	367.36M	604.88M	623.24M	715.19M	824.42M	1.15B	1.17B
Property, Plant & Equipment	6.65M	7.49M	10.66M	33.27M	57.74M	54.53M	60.16M	69.44M	72.05M	68.71M
Fixed Asset Turnover	60.27x	56.85x	48.61x	19.50x	13.25x	15.85x	15.81x	15.24x	16.02x	20.70x
Goodwill	73.91M	90.34M	135.44M	275.37M	469.07M	504.39M	582.84M	663M	970.56M	996.7M
Intangible Assets	15.41M	16.6M	23.78M	57.08M	71.55M	64.32M	72.19M	91.98M	109.64M	102.41M
Long-Term Investments	900K	-1.6M	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	1.6M	43K	0	0	0	0	0	0	0
Total Assets+	231.03M	267.11M	355.39M	636.75M	892.58M	947.59M	937.99M	1.02B	1.41B	1.44B
Asset Turnover	1.73x	1.59x	1.46x	1.02x	0.86x	0.91x	1.01x	1.03x	0.82x	0.99x
Asset Growth %	19.95%	15.62%	33.05%	79.17%	40.18%	6.16%	-1.01%	9.21%	37.9%	1.75%
Total Current Liabilities+	49.62M	52.17M	61.5M	87.53M	143.9M	117.69M	131.15M	145.12M	155.87M	149.49M
Accounts Payable	4.49M	7.38M	12.24M	19.64M	23.7M	19.36M	22.09M	26.18M	27.18M	16.83M
Days Payables Outstanding	5.56	8.69	11.76	15.27	16.07	11.87	12.38	13.3	12.72	6.4
Short-Term Debt	2.53M	3.1M	62K	728K	971K	9.77M	0	0	0	13.14M
Deferred Revenue (Current)	2.22M	1.06M	769K	0	32.09M	6.49M	12.91M	1.22M	11.24M	0
Other Current Liabilities	-16K	-1.06M	-769K	14.14M	17.96M	19.79M	17.37M	30.38M	13.64M	39.89M
Current Ratio	2.64x	2.98x	2.86x	3.08x	2.00x	2.76x	1.70x	1.38x	1.67x	1.80x
Quick Ratio	2.64x	2.98x	2.86x	3.08x	2.00x	2.76x	1.70x	1.38x	1.67x	1.80x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	22.48M	39.86M	18.1M	73.63M	230M	255.55M	173.31M	172.62M	286.27M	202.52M
Long-Term Debt	22.48M	39.86M	17.22M	59.16M	193.9M	220.91M	131.77M	124.13M	218.44M	158.22M
Capital Lease Obligations	0	0	0	14.3M	35.52M	32.86M	35.48M	39.71M	41.88M	37.26M
Deferred Tax Liabilities	0	8.41M	0	0	0	0	0	0	25.82M	44.06M
Other Non-Current Liabilities	0	446K	877K	163K	588K	1.78M	6.06M	8.77M	125K	-37.02M
Total Liabilities	72.1M	92.03M	79.86M	161.16M	373.91M	373.24M	304.45M	317.73M	442.14M	352M
Total Debt+	25.01M	42.96M	17.28M	81.43M	239.67M	263.55M	178.05M	175.18M	273.13M	208.62M
Net Debt	17M	-10.79M	-53.12M	-30.29M	94.59M	94.65M	98.09M	110.39M	174.22M	127M
Debt / Equity	0.16x	0.25x	0.06x	0.17x	0.46x	0.46x	0.28x	0.25x	0.28x	0.19x
Debt / EBITDA	1.13x	1.35x	0.55x	1.80x	4.24x	3.28x	2.15x	1.67x	2.35x	1.35x
Net Debt / EBITDA	0.77x	-0.34x	-1.69x	-0.67x	1.67x	1.18x	1.18x	1.05x	1.50x	0.82x
Interest Coverage	6.64x	5.65x	4.55x	11.19x	13.96x	11.36x	7.72x	8.19x	13.28x	14.46x
Total Equity+	158.93M	175.08M	275.53M	475.59M	518.68M	574.34M	633.54M	706.69M	970.49M	1.09B
Equity Growth %	12.14%	10.16%	57.38%	72.61%	9.06%	10.73%	10.31%	11.55%	37.33%	11.83%
Book Value per Share	13.79	15.05	20.99	33.38	32.51	35.75	39.15	43.33	55.84	58.83
Total Shareholders' Equity	158.93M	176.31M	275.53M	475.59M	518.68M	574.34M	633.54M	706.69M	970.49M	1.09B
Common Stock	12K	12K	13K	15K	16K	16K	16K	16K	18K	0
Retained Earnings	66.66M	80.33M	97.84M	116.03M	149.16M	194.29M	240.32M	302.83M	376.43M	0
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	-4.84M	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	-743K	52.77M	33.2M	12.02M	109.41M	39.49M	105.11M	112.25M	116.43M	111.51M
Operating CF Margin %	-0.19%	12.4%	6.41%	1.85%	14.31%	4.57%	11.05%	10.6%	10.08%	7.84%
Operating CF Growth %	-118.1%	7202.42%	-37.08%	-63.8%	810.32%	-63.91%	166.18%	6.79%	3.73%	-4.23%
Net Income	12.02M	13.61M	17.5M	25.24M	33.13M	45.13M	46.02M	62.52M	73.6M	95.91M
Depreciation & Amortization	6.65M	6.66M	8.64M	10.57M	12.05M	14.49M	14.06M	14.13M	13.53M	16.41M
Stock-Based Compensation	1.07M	2.55M	4.11M	5.77M	6M	9.43M	10.63M	10.32M	11.16M	0
Deferred Taxes	-1.33M	1.75M	-43K	-1.06M	-4.65M	7.28M	3.91M	2.82M	13.19M	0
Other Non-Cash Items	10.28M	8.04M	69K	1.06M	2.91M	1.77M	2.71M	1.58M	3.44M	-815K
Working Capital Changes	-29.44M	20.15M	2.92M	-29.55M	59.96M	-38.61M	27.78M	20.89M	1.51M	0
Change in Receivables	-32.61M	21.02M	-2.17M	-37.48M	23.86M	-3.92M	20.59M	15.67M	22.14M	0
Change in Inventory	-76.69M	-99.56M	-123.14M	0	0	-1.97M	0	0	0	0
Change in Payables	-1.53M	-229K	4.24M	4.64M	2.16M	-4.81M	2.51M	2.02M	-1.91M	0
Cash from Investing+	-21.74M	-24.27M	-67.79M	-188.7M	-214.24M	-42.02M	-106.59M	-119.24M	-354.61M	-32.5M
Capital Expenditures	-1.71M	-3.62M	-5.35M	-4.62M	-6.83M	-4.64M	-8.3M	-9.45M	-6.05M	0
CapEx % of Revenue	0.43%	0.85%	1.03%	0.71%	0.89%	0.54%	0.87%	0.89%	0.52%	7.84%
Acquisitions	-20.03M	-24.35M	-62.44M	-184.08M	-207.41M	-37.37M	-98.29M	-109.8M	-348.59M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-21.74M	3.7M	0	0	0	0	0	15K	29K	-32.5M
Cash from Financing+	26.39M	17.24M	51.24M	217.99M	138.19M	26.34M	-87.45M	-8.18M	272.3M	-96.3M
Debt Issued (Net)	22.89M	18.94M	-25.45M	42.26M	134.24M	28.27M	-90M	-8.5M	96.65M	0
Equity Issued (Net)	0	0	1000K	1000K	1000K	1000K	1000K	319K	1000K	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0
Other Financing	3.5M	-1.7M	71K	2.78M	0	-3.03M	0	0	49K	-96.3M
Net Change in Cash	3.91M	45.74M	16.65M	41.31M	33.36M	23.82M	-88.93M	-15.17M	34.12M	-17.29M
Free Cash Flow+	-2.46M	49.16M	27.85M	7.4M	102.58M	34.84M	96.81M	102.79M	110.38M	0
FCF Margin %	-0.61%	11.55%	5.38%	1.14%	13.41%	4.03%	10.18%	9.71%	9.56%	-
FCF Growth %	-240.53%	2102.24%	-43.33%	-73.44%	1286.59%	-66.03%	177.85%	6.18%	7.38%	-100%
FCF per Share	-0.21	4.23	2.12	0.52	6.43	2.17	5.98	6.30	6.35	-
FCF Conversion (FCF/Net Income)	-0.06x	3.88x	1.90x	0.48x	3.30x	0.88x	2.28x	1.80x	1.58x	1.16x
Interest Paid	2.32M	2.26M	4.34M	2.32M	2.37M	5.09M	7.99M	10.25M	6.52M	0
Taxes Paid	5.09M	6.72M	4.1M	7.3M	10.59M	17.82M	1.48M	14.98M	26.25M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	8%	8.15%	7.77%	6.72%	6.66%	8.26%	7.62%	9.33%	8.78%	9.33%
Return on Invested Capital (ROIC)	7.33%	11.13%	8.85%	7.81%	6.31%	7.71%	7.36%	8.81%	7.85%	8.82%
Gross Margin	26.48%	27.15%	26.69%	27.63%	29.58%	31.21%	31.51%	32.1%	32.48%	32.47%
Net Margin	3%	3.2%	3.38%	3.89%	4.33%	5.22%	4.84%	5.91%	6.37%	6.74%
Debt / Equity	0.16x	0.25x	0.06x	0.17x	0.46x	0.46x	0.28x	0.25x	0.28x	0.19x
Interest Coverage	6.64x	5.65x	4.55x	11.19x	13.96x	11.36x	7.72x	8.19x	13.28x	14.46x
FCF Conversion	-0.06x	3.88x	1.90x	0.48x	3.30x	0.88x	2.28x	1.80x	1.58x	1.16x
Revenue Growth	18.96%	6.25%	21.71%	25.22%	17.88%	13.04%	10.02%	11.31%	9.06%	23.21%

US Stock Screener

...

Addus HomeCare Corporation (ADUS) 10-Year Financial Performance & Capital Metrics

ADUS •

HealthcareHealthcare FacilitiesHome-based care services

Revenue $1.42B +23.2%
EBITDA $155M +33.4%
Net Income $96M +30.3%
EPS (Diluted) 5.21 +23.2%
Gross Margin 32.47%
EBITDA Margin 10.9% +8.3%
Operating Margin 9.74% +9.6%
Net Margin 6.74% +5.8%
ROE 9.33% +6.3%
ROIC 8.82% +12.3%
Debt/Equity 0.19 -31.7%
Interest Coverage 14.46 +8.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 23.7%
✓Strong Piotroski F-Score: 7/9
✓Strong 5Y sales CAGR of 13.2%

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y15.5%

5Y13.22%

3Y14.36%

TTM23.21%

Profit (Net Income) CAGR

10Y23.5%

5Y23.69%

3Y27.73%

TTM30.32%

EPS CAGR

10Y17.48%

5Y20.16%

3Y22.42%

TTM22.88%

ROCE

10Y Avg9.42%

5Y Avg9.61%

3Y Avg10.43%

Latest10.89%

Peer Comparison

Home-based care services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
OPCHOption Care Health, Inc.	5.09B	32.46	25.36	13.03%	3.67%	15.65%	5.08%
CHEChemed Corporation	5.78B	410.01	22.26	4.06%	10.48%	27.08%	5.63%	0.15
ADUSAddus HomeCare Corporation	1.92B	103.53	19.87	23.21%	6.74%	8.84%		0.19
DCGODocGo Inc.	73.17M	0.72	3.99	-1.24%	-14.02%	-19.79%	88.15%	0.18
EHABEnhabit, Inc.	685.94M	13.61	-4.38	-1.1%	-1.14%	-1.99%	6.91%	1.03
AVAHAveanna Healthcare Holdings Inc.	1.53B	7.36	-129.81	6.82%	0.85%		1.72%

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	400.69M	425.71M	518.12M	648.79M	764.77M	864.5M	951.12M	1.06B	1.15B	1.42B
Revenue Growth %	18.96%	6.25%	21.71%	25.22%	17.88%	13.04%	10.02%	11.31%	9.06%	23.21%
Cost of Goods Sold+	294.59M	310.12M	379.84M	469.55M	538.54M	595.24M	651.38M	718.77M	779.58M	960.66M
COGS % of Revenue	73.52%	72.85%	73.31%	72.37%	70.42%	68.85%	68.49%	67.9%	67.52%	67.53%
Gross Profit+	106.09M	115.6M	138.28M	179.24M	226.24M	269.85M	299.74M	339.88M	375.02M	461.87M
Gross Margin %	26.48%	27.15%	26.69%	27.63%	29.58%	31.21%	31.51%	32.1%	32.48%	32.47%
Gross Profit Growth %	16.18%	8.96%	19.62%	29.62%	26.22%	19.28%	11.08%	13.39%	10.34%	23.16%
Operating Expenses+	90.86M	91.82M	113.94M	144.49M	181.73M	203.32M	231M	248.92M	272.33M	323.26M
OpEx % of Revenue	22.68%	21.57%	21.99%	22.27%	23.76%	23.52%	24.29%	23.51%	23.59%	22.72%
Selling, General & Admin	84.21M	76.9M	105.03M	133.57M	169.68M	189.42M	216.94M	231.68M	258.8M	306.85M
SG&A % of Revenue	21.02%	18.06%	20.27%	20.59%	22.19%	21.91%	22.81%	21.88%	22.41%	21.57%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	6.65M	14.92M	8.91M	10.92M	12.05M	13.9M	14.06M	17.24M	13.53M	16.41M
Operating Income+	15.48M	25.25M	22.83M	34.75M	44.51M	65.94M	68.74M	90.96M	102.69M	138.62M
Operating Margin %	3.86%	5.93%	4.41%	5.36%	5.82%	7.63%	7.23%	8.59%	8.89%	9.74%
Operating Income Growth %	-3.42%	63.18%	-9.61%	52.24%	28.07%	48.15%	4.25%	32.32%	12.9%	34.98%
EBITDA+	22.12M	31.92M	31.47M	45.33M	56.56M	80.43M	82.8M	105.08M	116.22M	155.03M
EBITDA Margin %	5.52%	7.5%	6.07%	6.99%	7.4%	9.3%	8.71%	9.93%	10.07%	10.9%
EBITDA Growth %	6.66%	44.27%	-1.4%	44.03%	24.78%	42.21%	2.94%	26.92%	10.6%	33.39%
D&A (Non-Cash Add-back)	6.65M	6.66M	8.64M	10.57M	12.05M	14.49M	14.06M	14.13M	13.53M	16.41M
EBIT	18.25M	26.65M	25.42M	36.27M	45.13M	66.2M	69.08M	92.43M	107.08M	137.03M
Net Interest Income+	480K	-4.41M	-2.42M	-1.58M	-2.56M	-5.54M	-8.57M	-9.63M	-3.34M	-8M
Interest Income	2.81M	66K	2.59M	1.52M	624K	268K	341K	1.48M	4.39M	1.59M
Interest Expense	2.33M	4.47M	5.02M	3.1M	3.19M	5.81M	8.91M	11.11M	7.73M	9.58M
Other Income/Expense	686K	-5.17M	-2.42M	-1.58M	-2.56M	-5.54M	-8.57M	-9.63M	-3.34M	-11.17M
Pretax Income+	16.16M	21.06M	20.4M	33.17M	41.94M	60.4M	60.17M	81.33M	99.35M	127.44M
Pretax Margin %	4.03%	4.95%	3.94%	5.11%	5.48%	6.99%	6.33%	7.68%	8.61%	8.96%
Income Tax+	4.1M	9.26M	4.1M	7.36M	8.81M	15.27M	14.15M	18.81M	25.75M	31.54M
Effective Tax Rate %	74.4%	64.6%	85.79%	76.08%	79%	74.71%	76.49%	76.87%	74.08%	75.26%
Net Income+	12.02M	13.61M	17.5M	25.24M	33.13M	45.13M	46.02M	62.52M	73.6M	95.91M
Net Margin %	3%	3.2%	3.38%	3.89%	4.33%	5.22%	4.84%	5.91%	6.37%	6.74%
Net Income Growth %	3.45%	13.17%	28.62%	44.19%	31.29%	36.2%	1.99%	35.83%	17.73%	30.32%
Net Income (Continuing)	12.06M	13.53M	16.31M	25.81M	33.13M	45.13M	46.02M	62.52M	73.6M	95.91M
Discontinued Operations	97K	147K	126K	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	1.04	1.17	1.33	1.77	2.08	2.81	2.84	3.83	4.23	5.21
EPS Growth %	0%	12.5%	13.68%	33.08%	17.51%	35.1%	1.07%	34.86%	10.44%	23.17%
EPS (Basic)	1.04	1.17	1.33	1.83	2.12	2.87	2.90	3.91	4.33	5.19
Diluted Shares Outstanding	11.53M	11.63M	13.13M	14.25M	15.96M	16.06M	16.18M	16.31M	17.38M	18.45M
Basic Shares Outstanding	11.29M	11.47M	13.13M	13.82M	15.83M	15.74M	16.13M	16.23M	17.01M	18.45M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	131.01M	155.67M	176.01M	269.39M	287.7M	324.34M	222.81M	200M	260.38M	269.49M
Cash & Short-Term Investments	8.01M	53.75M	70.41M	111.71M	145.08M	168.9M	79.96M	64.79M	98.91M	81.62M
Cash Only	8.01M	53.75M	70.41M	111.71M	145.08M	168.9M	79.96M	64.79M	98.91M	81.62M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	117.75M	93.53M	100.57M	153.24M	134.51M	146.07M	126.17M	116.08M	135.26M	151.69M
Days Sales Outstanding	107.26	80.19	70.85	86.21	64.2	61.67	48.42	40.02	42.76	38.92
Inventory	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	1.82M	4.7M	5.04M	2.4M	2.18M	2.49M	5.39M	2.23M	7.83M	36.18M
Total Non-Current Assets+	100.02M	116.03M	169.88M	367.36M	604.88M	623.24M	715.19M	824.42M	1.15B	1.17B
Property, Plant & Equipment	6.65M	7.49M	10.66M	33.27M	57.74M	54.53M	60.16M	69.44M	72.05M	68.71M
Fixed Asset Turnover	60.27x	56.85x	48.61x	19.50x	13.25x	15.85x	15.81x	15.24x	16.02x	20.70x
Goodwill	73.91M	90.34M	135.44M	275.37M	469.07M	504.39M	582.84M	663M	970.56M	996.7M
Intangible Assets	15.41M	16.6M	23.78M	57.08M	71.55M	64.32M	72.19M	91.98M	109.64M	102.41M
Long-Term Investments	900K	-1.6M	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	1.6M	43K	0	0	0	0	0	0	0
Total Assets+	231.03M	267.11M	355.39M	636.75M	892.58M	947.59M	937.99M	1.02B	1.41B	1.44B
Asset Turnover	1.73x	1.59x	1.46x	1.02x	0.86x	0.91x	1.01x	1.03x	0.82x	0.99x
Asset Growth %	19.95%	15.62%	33.05%	79.17%	40.18%	6.16%	-1.01%	9.21%	37.9%	1.75%
Total Current Liabilities+	49.62M	52.17M	61.5M	87.53M	143.9M	117.69M	131.15M	145.12M	155.87M	149.49M
Accounts Payable	4.49M	7.38M	12.24M	19.64M	23.7M	19.36M	22.09M	26.18M	27.18M	16.83M
Days Payables Outstanding	5.56	8.69	11.76	15.27	16.07	11.87	12.38	13.3	12.72	6.4
Short-Term Debt	2.53M	3.1M	62K	728K	971K	9.77M	0	0	0	13.14M
Deferred Revenue (Current)	2.22M	1.06M	769K	0	32.09M	6.49M	12.91M	1.22M	11.24M	0
Other Current Liabilities	-16K	-1.06M	-769K	14.14M	17.96M	19.79M	17.37M	30.38M	13.64M	39.89M
Current Ratio	2.64x	2.98x	2.86x	3.08x	2.00x	2.76x	1.70x	1.38x	1.67x	1.80x
Quick Ratio	2.64x	2.98x	2.86x	3.08x	2.00x	2.76x	1.70x	1.38x	1.67x	1.80x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	22.48M	39.86M	18.1M	73.63M	230M	255.55M	173.31M	172.62M	286.27M	202.52M
Long-Term Debt	22.48M	39.86M	17.22M	59.16M	193.9M	220.91M	131.77M	124.13M	218.44M	158.22M
Capital Lease Obligations	0	0	0	14.3M	35.52M	32.86M	35.48M	39.71M	41.88M	37.26M
Deferred Tax Liabilities	0	8.41M	0	0	0	0	0	0	25.82M	44.06M
Other Non-Current Liabilities	0	446K	877K	163K	588K	1.78M	6.06M	8.77M	125K	-37.02M
Total Liabilities	72.1M	92.03M	79.86M	161.16M	373.91M	373.24M	304.45M	317.73M	442.14M	352M
Total Debt+	25.01M	42.96M	17.28M	81.43M	239.67M	263.55M	178.05M	175.18M	273.13M	208.62M
Net Debt	17M	-10.79M	-53.12M	-30.29M	94.59M	94.65M	98.09M	110.39M	174.22M	127M
Debt / Equity	0.16x	0.25x	0.06x	0.17x	0.46x	0.46x	0.28x	0.25x	0.28x	0.19x
Debt / EBITDA	1.13x	1.35x	0.55x	1.80x	4.24x	3.28x	2.15x	1.67x	2.35x	1.35x
Net Debt / EBITDA	0.77x	-0.34x	-1.69x	-0.67x	1.67x	1.18x	1.18x	1.05x	1.50x	0.82x
Interest Coverage	6.64x	5.65x	4.55x	11.19x	13.96x	11.36x	7.72x	8.19x	13.28x	14.46x
Total Equity+	158.93M	175.08M	275.53M	475.59M	518.68M	574.34M	633.54M	706.69M	970.49M	1.09B
Equity Growth %	12.14%	10.16%	57.38%	72.61%	9.06%	10.73%	10.31%	11.55%	37.33%	11.83%
Book Value per Share	13.79	15.05	20.99	33.38	32.51	35.75	39.15	43.33	55.84	58.83
Total Shareholders' Equity	158.93M	176.31M	275.53M	475.59M	518.68M	574.34M	633.54M	706.69M	970.49M	1.09B
Common Stock	12K	12K	13K	15K	16K	16K	16K	16K	18K	0
Retained Earnings	66.66M	80.33M	97.84M	116.03M	149.16M	194.29M	240.32M	302.83M	376.43M	0
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	-4.84M	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	-743K	52.77M	33.2M	12.02M	109.41M	39.49M	105.11M	112.25M	116.43M	111.51M
Operating CF Margin %	-0.19%	12.4%	6.41%	1.85%	14.31%	4.57%	11.05%	10.6%	10.08%	7.84%
Operating CF Growth %	-118.1%	7202.42%	-37.08%	-63.8%	810.32%	-63.91%	166.18%	6.79%	3.73%	-4.23%
Net Income	12.02M	13.61M	17.5M	25.24M	33.13M	45.13M	46.02M	62.52M	73.6M	95.91M
Depreciation & Amortization	6.65M	6.66M	8.64M	10.57M	12.05M	14.49M	14.06M	14.13M	13.53M	16.41M
Stock-Based Compensation	1.07M	2.55M	4.11M	5.77M	6M	9.43M	10.63M	10.32M	11.16M	0
Deferred Taxes	-1.33M	1.75M	-43K	-1.06M	-4.65M	7.28M	3.91M	2.82M	13.19M	0
Other Non-Cash Items	10.28M	8.04M	69K	1.06M	2.91M	1.77M	2.71M	1.58M	3.44M	-815K
Working Capital Changes	-29.44M	20.15M	2.92M	-29.55M	59.96M	-38.61M	27.78M	20.89M	1.51M	0
Change in Receivables	-32.61M	21.02M	-2.17M	-37.48M	23.86M	-3.92M	20.59M	15.67M	22.14M	0
Change in Inventory	-76.69M	-99.56M	-123.14M	0	0	-1.97M	0	0	0	0
Change in Payables	-1.53M	-229K	4.24M	4.64M	2.16M	-4.81M	2.51M	2.02M	-1.91M	0
Cash from Investing+	-21.74M	-24.27M	-67.79M	-188.7M	-214.24M	-42.02M	-106.59M	-119.24M	-354.61M	-32.5M
Capital Expenditures	-1.71M	-3.62M	-5.35M	-4.62M	-6.83M	-4.64M	-8.3M	-9.45M	-6.05M	0
CapEx % of Revenue	0.43%	0.85%	1.03%	0.71%	0.89%	0.54%	0.87%	0.89%	0.52%	7.84%
Acquisitions	-20.03M	-24.35M	-62.44M	-184.08M	-207.41M	-37.37M	-98.29M	-109.8M	-348.59M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-21.74M	3.7M	0	0	0	0	0	15K	29K	-32.5M
Cash from Financing+	26.39M	17.24M	51.24M	217.99M	138.19M	26.34M	-87.45M	-8.18M	272.3M	-96.3M
Debt Issued (Net)	22.89M	18.94M	-25.45M	42.26M	134.24M	28.27M	-90M	-8.5M	96.65M	0
Equity Issued (Net)	0	0	1000K	1000K	1000K	1000K	1000K	319K	1000K	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0
Other Financing	3.5M	-1.7M	71K	2.78M	0	-3.03M	0	0	49K	-96.3M
Net Change in Cash	3.91M	45.74M	16.65M	41.31M	33.36M	23.82M	-88.93M	-15.17M	34.12M	-17.29M
Free Cash Flow+	-2.46M	49.16M	27.85M	7.4M	102.58M	34.84M	96.81M	102.79M	110.38M	0
FCF Margin %	-0.61%	11.55%	5.38%	1.14%	13.41%	4.03%	10.18%	9.71%	9.56%	-
FCF Growth %	-240.53%	2102.24%	-43.33%	-73.44%	1286.59%	-66.03%	177.85%	6.18%	7.38%	-100%
FCF per Share	-0.21	4.23	2.12	0.52	6.43	2.17	5.98	6.30	6.35	-
FCF Conversion (FCF/Net Income)	-0.06x	3.88x	1.90x	0.48x	3.30x	0.88x	2.28x	1.80x	1.58x	1.16x
Interest Paid	2.32M	2.26M	4.34M	2.32M	2.37M	5.09M	7.99M	10.25M	6.52M	0
Taxes Paid	5.09M	6.72M	4.1M	7.3M	10.59M	17.82M	1.48M	14.98M	26.25M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	8%	8.15%	7.77%	6.72%	6.66%	8.26%	7.62%	9.33%	8.78%	9.33%
Return on Invested Capital (ROIC)	7.33%	11.13%	8.85%	7.81%	6.31%	7.71%	7.36%	8.81%	7.85%	8.82%
Gross Margin	26.48%	27.15%	26.69%	27.63%	29.58%	31.21%	31.51%	32.1%	32.48%	32.47%
Net Margin	3%	3.2%	3.38%	3.89%	4.33%	5.22%	4.84%	5.91%	6.37%	6.74%
Debt / Equity	0.16x	0.25x	0.06x	0.17x	0.46x	0.46x	0.28x	0.25x	0.28x	0.19x
Interest Coverage	6.64x	5.65x	4.55x	11.19x	13.96x	11.36x	7.72x	8.19x	13.28x	14.46x
FCF Conversion	-0.06x	3.88x	1.90x	0.48x	3.30x	0.88x	2.28x	1.80x	1.58x	1.16x
Revenue Growth	18.96%	6.25%	21.71%	25.22%	17.88%	13.04%	10.02%	11.31%	9.06%	23.21%

Addus HomeCare Corporation (ADUS) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare ADUS vs Peers

vs CHE

vs OPCH

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Addus HomeCare Corporation (ADUS) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare ADUS vs Peers

vs CHE

vs OPCH

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios